Zhao Long Gong
Directeur Général chez 3D MEDICINES INC.
Fortune : 30 M $ au 30/04/2024
Profil
Zhao Long Gong is the Chairman & Chief Executive Officer and founder of 3D Medicines, Inc. which is founded in 2014.
He is currently an Independent Director at Shanghai Innostar Biotechnology Co., Ltd.
since 2021.
Dr. Gong was previously an Independent Director at Shandong Jincheng Pharmaceutical Group Co., Ltd.
and Staidson (Beijing) Biopharmaceuticals Co., Ltd.
from 2015 to 2021.
Dr. Gong received his doctorate degree from New York University in 1996 and his undergraduate and graduate degrees from Peking University Health Science Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
3D MEDICINES, INC.
13,94% | 05/04/2024 | 35 992 364 ( 13,94% ) | 30 M $ | 30/04/2024 |
Postes actifs de Zhao Long Gong
| Sociétés | Poste | Début |
|---|---|---|
| 3D MEDICINES INC. | Directeur Général | 01/01/2014 |
Shanghai Innostar Biotechnology Co., Ltd.
 Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Directeur/Membre du Conseil | 13/08/2021 |
Anciens postes connus de Zhao Long Gong
| Sociétés | Poste | Fin |
|---|---|---|
| SHANDONG JINCHENG PHARMACEUTICAL GROUP CO., LTD | Directeur/Membre du Conseil | 12/05/2023 |
| STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD. | Directeur/Membre du Conseil | 11/08/2021 |
Formation de Zhao Long Gong
| New York University | Doctorate Degree |
| Peking University Health Science Center | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD. | Health Technology |
| SHANDONG JINCHENG PHARMACEUTICAL GROUP CO., LTD | Health Technology |
| 3D MEDICINES INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Shanghai Innostar Biotechnology Co., Ltd.
Shanghai Innostar Biotechnology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Innostar Biotechnology Co., Ltd. engages in the provision of comprehensive research and development services for biopharmaceutical non-clinical research. Its services include early-stage drug discovery, clinical testing & translational research, non-clinical safety evaluation, non-clinical pharmacokinetic studies, and non-clinical pharmacodynamic studies. The company was founded on May 12, 2010 and is headquartered in Shanghai, China. | Commercial Services |